Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value:
$281.9K
Total Bought:
$25.4K
Total Sold:
$29.9K
Net Transaction:
-$4.5K
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Exelixis, Inc.(EXEL)1,899,1511,899,079-72$41.5K$45.6K16.16%+$4.1K
United Therapeutics Corporation(UTHR)201,222200,872-350$45.5K$44.2K15.67%-$1.3K
Biogen Inc.(BIIB)160,480160,4800$41.2K$41.5K14.73%+$282
Regeneron Pharmaceuticals, Inc.(REGN)47,25647,2560$38.9K$41.5K14.73%+$2.6K
Cardinal Health, Inc.(CAH)291,319281,476-9,843$25.3K$28.4K10.07%+$3.1K
Taro Pharmaceutical Indus640,735646,453+5,718$24.2K$27.0K9.58%+$2.8K
Alkermes plc(ALKS)906,060918,038+11,978$25.4K$25.5K9.04%+$87
Jazz Pharmaceuticals plc(JAZZ)0100,000+100,000$0$12.3K4.36%+$12.3K
Sanofi(SNY)0150,400+150,400$0$7.5K2.65%+$7.5K
Enanta Pharmaceuticals, Inc.(ENTA)735,103742,824+7,721$8.2K$7.0K2.48%-$1.2K
Masimo Corp08,000+8,000$0$9380.33%+$938
Mural Oncology Plc090,833+90,833$0$5380.19%+$538
EAGLE PHARMACEUTICALS INCCOM112,6660-112,666$1.8K$0—-$1.8K
EMBECTA CORPCOM(EMBC)1,164,8760-1,164,876$17.5K$0—-$17.5K
KODIAK SCIENCES INCCOM(KOD)342,3120-342,312$616$0—-$616
VANDA PHARMACEUTICALS INCCOM(VNDA)360,4290-360,429$1.6K$0—-$1.6K
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q4 2023 | TickerTrail